| |
 |
SYM |
Description |
|
|
CNSO |
rEEG technology for the assessment of neurophysiological abnormalities and determination of psychiatric treatment |
 |
|
|
|
|
|
|
|
SURG |
Micro or minimally invasive products for ophthalmic and neurosurgery.
|
|
|
|
|
|
|
 |
|
Private |
Implantable devices for the treatment of neurological disorders by responsive brain stimulation. |
|
|
|
|
|
|
|
|
CYBX |
Implantable medical devices for neurological disorders including epilepsy |
|
|
|
|
|
|
|
|
CYKNE |
Therapeutic neurotechnology procedures for the treatment of nervous system conditions, including spinal cord and peripheral nerve injury |
|
|
|
|
|
|
|
|
Private |
Real-time Functional MRI Technology to Modify Cognitive Perception and Treat Chronic Pain
|
|
|
|
|
|
|
|
|
Private |
InterveXion Therapeutics is a pharmaceutical company developing passive and active antibody-based medications for the treatment of substance abuse and addiction. Our first medications are monoclonal antibodies (mAb) for treating phencyclidine (PCP) and methamphetamine (METH) abuse. |
|
|
|
|
|
|
|
|
GLFD |
Products for neurology and hospital markets. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private |
Functional diagnostics in the field of urodynamics, gastroenterology and neurology. |
|
|
|
|
|
|
|
|
CMP |
Computer based diagnostic technologies in the areas of sleep, Neurology and Cardiology. |
|
|
|
|
|
|
|
|
SOMX |
Drugs for the areas of psychiatry and neurology. |
|
|
|
|
|
|
|
|
Private |
Specialy pharmaceuticals for oncology, urology and neurology |
|
|
|
|
|
|
|
|
Private |
Products used for cardiology and neurology applications |
|
|
|
|
|
|
|
|
Private |
Pharmaceutical products, primarily in the areas of neurology, dermatology and infectious disease. |
|
|
|
|
|
|
|
|
EVVV |
Edovascular technologies for interventional radiology, cardiology, and neurology therapies. |
|
|
|
|
|
|
|
|
TAROF |
Dermatological products and a line of solid dosage products used mainly in cardiology and neurology. |
|
|
|
|
|
|
|
|
Private |
Gastroenterology, Neurology & Psychiatry and Pain Treatment. |
|
|
|
|
|
|
|
|
SRZ |
Drugs for neurology, urology and cardiovascular diseases. |
|
|
|
|
|
|
|
|
Private |
Contract research organization for clinical trials in oncology, neurology and diabetology. |
|
|
|
|
|
|
|
|
Private |
Products for neurology, genetic disorders, haematology, nephrology, oncology and rheumatolgy. |
|
|
|
|
|
|
|
|
|
Interventional neurology. |
|
|
|
|
|
|
|
|
Private |
Medical devices for patients with neurological disabilities. |
|
|
|
|
|
|
|
|
Private |
Genetic therapeutics for the treatment of neurological disorders. |
|
|
|
|
|
|
|
|
Private |
Drugs to treat serious neurological, psychiatric and pain disorders. |
|
|
|
|
|
|
|
|
NBIX |
Drugs for neurologic and endocrine system-related diseases. |
|
|
|
|
|
|
|
|
Private |
Technology for the management and treatment of neurological disorders. |
|
|
|
|
|
|
|
|
NTII |
Neuroprotective and neuromodulatory agents to treat progressive neurological impairments. |
|
|
|
|
|
|
|
|
Private |
Novel therapies for improving cerebral perfusion
|
|
|
|
|
|
|
|
|
Private |
Advanced Brain Interface Devices for Neurological and Neurosurgical Applications |
|
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
OneMedPlace Member
